Your cat was diagnosed with Oral Squamous Cell Carcinoma. Most common oral malignancy in cats. Extremely aggressive with very poor prognosis. MST untreated 44-60 days. <10% one-year survival with any treatment. Compare 5 treatment options for cats including Mandibulectomy / Maxillectomy, Radiation + Carboplatin (Concomitant), Toceranib (Palladia) — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Oral Squamous Cell Carcinoma
Feline Oncology Treatment Guide
Oral Squamous Cell Carcinoma
variable
Epithelial
About This Cancer
Oral squamous cell carcinoma is the most common malignant tumour of the mouth in cats and carries an extremely poor prognosis. The cancer arises from the squamous epithelial cells lining the oral cavity, most frequently under the tongue (sublingual) or along the gums. It is aggressively invasive locally, rapidly destroying bone and soft tissue, and affected cats often present with drooling, difficulty eating, bloody oral discharge, or weight loss. Without treatment, survival is typically only one to two months. Unfortunately, even with aggressive treatment combinations (surgery, radiation, chemotherapy), long-term survival remains poor — fewer than 10% of cats survive one year. The cancer's resistance to treatment and the anatomical challenges of the feline mouth make this one of the most difficult cancers to manage in veterinary oncology.
WHO TNM Staging for Feline Oral Tumours
Based on tumour size, lymph node involvement, and distant metastasis. Adapted from canine oral tumour staging.
Prognostic Factors(3)
Minimum Workup(5 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.